Search clinical trials for: Vaccine: 2.6±0.8 x 10^11 vp/mL, 3 doses
Total 11 results
-
PATHCompleted
-
Auro Vaccines LLCUnited States Department of Defense; AccelovanceCompletedEbola Virus DiseaseUnited States
-
Crucell Holland BVThe PATH Malaria Vaccine Initiative (MVI); Seattle Children's Research Institute...Completed
-
Hamilton Health Sciences CorporationUniversity Health Network, Toronto; Dartmouth-Hitchcock Medical Center; Ottawa... and other collaboratorsTerminated
-
Merck Sharp & Dohme LLCCompleted
-
University of Michigan Rogel Cancer CenterRush University Medical CenterCompletedPancreatic CancerUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedHypoxic Ischemic EncephalopathyFrance
-
Medical University of ViennaCompletedVaccine Responsiveness in Allergy | Vaccine Responsiveness During Allergy De-sensitization TreatmentAustria
-
Locus BiosciencesParexelRecruitingUrinary Tract InfectionsUnited States
-
National Cancer Institute (NCI)CompletedStage IV Adult Soft Tissue Sarcoma | Adult Rhabdomyosarcoma | Metastatic Childhood Soft Tissue Sarcoma | Childhood Alveolar Rhabdomyosarcoma | Childhood Embryonal Rhabdomyosarcoma | Untreated Childhood RhabdomyosarcomaUnited States, Canada, Australia, New Zealand
-
Baskent UniversityCompletedElective Caesarean Section SurgeriesTurkey